JP2013502217A5 - - Google Patents

Download PDF

Info

Publication number
JP2013502217A5
JP2013502217A5 JP2012525639A JP2012525639A JP2013502217A5 JP 2013502217 A5 JP2013502217 A5 JP 2013502217A5 JP 2012525639 A JP2012525639 A JP 2012525639A JP 2012525639 A JP2012525639 A JP 2012525639A JP 2013502217 A5 JP2013502217 A5 JP 2013502217A5
Authority
JP
Japan
Prior art keywords
seq
arnox
amino acids
host cell
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012525639A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013502217A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/045745 external-priority patent/WO2011022387A1/en
Publication of JP2013502217A publication Critical patent/JP2013502217A/ja
Publication of JP2013502217A5 publication Critical patent/JP2013502217A5/ja
Withdrawn legal-status Critical Current

Links

JP2012525639A 2009-08-17 2010-08-17 arNOXタンパク質9回膜貫通型スーパーファミリー(TM9SF)のクローニング及び発現、方法並びに利用 Withdrawn JP2013502217A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23436809P 2009-08-17 2009-08-17
US61/234,368 2009-08-17
PCT/US2010/045745 WO2011022387A1 (en) 2009-08-17 2010-08-17 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility

Publications (2)

Publication Number Publication Date
JP2013502217A JP2013502217A (ja) 2013-01-24
JP2013502217A5 true JP2013502217A5 (enExample) 2013-10-03

Family

ID=43607300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012525639A Withdrawn JP2013502217A (ja) 2009-08-17 2010-08-17 arNOXタンパク質9回膜貫通型スーパーファミリー(TM9SF)のクローニング及び発現、方法並びに利用

Country Status (7)

Country Link
US (1) US20120315629A1 (enExample)
EP (1) EP2467392A4 (enExample)
JP (1) JP2013502217A (enExample)
CN (1) CN102574889A (enExample)
CA (1) CA2771277A1 (enExample)
IN (1) IN2012DN02304A (enExample)
WO (1) WO2011022387A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011109525A1 (en) 2010-03-02 2011-09-09 Nox Technologies, Inc. Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof
EP3013961A1 (en) * 2013-06-25 2016-05-04 Mor-Nuco Enterprises, Inc. Growth-related enox proteins from plants with yield enhancement potential, sequences and methods
CN114774418B (zh) * 2022-04-19 2023-11-14 深圳市人民医院 shRNA分子及其在敲低TM9SF2基因表达中的应用
CN115772574A (zh) * 2022-10-27 2023-03-10 华南农业大学 鸡tm9sf2基因鉴定方法及其膜外结构域的原核表达

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175787A1 (en) * 1997-10-28 2003-09-18 Incyte Corporation Vesicle membrane proteins
WO2005003766A2 (en) * 2003-06-13 2005-01-13 Whitehead Institute For Biomedical Research Methods of regulating metabolism and mitochondrial function
US7473531B1 (en) * 2003-08-08 2009-01-06 Colora Corporation Pancreatic cancer targets and uses thereof
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
US7935808B2 (en) * 2007-03-30 2011-05-03 Abbott Laboratories Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
ES2587055T3 (es) * 2008-01-25 2016-10-20 Hansabiomed Ou Una nueva molécula asociada a tumores humanos metastásicos, métodos para detectar tanto el gen activado como la proteína y para interferir con la expresión génica

Similar Documents

Publication Publication Date Title
EP3319633B1 (en) Vaccine against rsv
EP2585107B1 (en) Homodimeric protein constructs
JP2005046146A5 (enExample)
JP2005120106A5 (enExample)
JP2004267216A5 (enExample)
JP2006081548A5 (enExample)
RU2012132442A (ru) Антитело к cd27
CN105073196B (zh) 呼吸道合胞病毒f蛋白表位
JP2014506790A5 (enExample)
JP2009527226A5 (enExample)
US20190153406A1 (en) MG53 Mutants, Methods of Making the Same, and Uses Thereof
JP2012095652A5 (enExample)
JP2010273685A5 (enExample)
JP2022062113A5 (enExample)
RU2012106148A (ru) Вариантные формы уратоксидазы и их применение
CN110845622A (zh) 不同结构域缺失融合蛋白的制备及其在提高蛋白质合成的应用
JPWO2021219897A5 (enExample)
JP2013502217A5 (enExample)
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
JP2003504020A5 (enExample)
JP2010514698A5 (enExample)
JP2003530821A5 (enExample)
US20230106770A1 (en) Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (SARS) coronavirus infection
TW200716166A (en) Lawsonia intracellularis immunological proteins
JPWO2021226348A5 (enExample)